Editorial Board of CML Lung Cancer

Editorial Board

Editorial Advisory Board 
 
Cesare Gridelli
Director, Department of Oncology/Hematology, and Head, Division of Medical Oncology,
SG Moscati Hospital, Avellino, Italy

 
Heine H Hansen
Professor of Medicine,
Rigshospitalet, Copenhagen, Denmark

 
Primo N Lara, Jr
Professor of Medicine and Director, Clinical Trials Support Unit,
University of California, Sacramento, CA, USA

 
Martin Muers
Consultant Physician,
The General Infirmary at Leeds, Leeds, UK

 
Egbert F Smit
Professor of Pulmonary Medicine,
Vrije Universiteit Medical Centre, Amsterdam, The Netherlands

 
Johan Vansteenkiste
Professor of Thoracic Oncology,
University Hospital Gasthuisberg, Leuven, Belgium


Clinical Editors

Luigi De Petris
Medical Oncologist,
Karolinska Institutet, Stockholm, Sweden


Christophe Dooms
Pulmonary Medicine, University Hospitals Leuven, Leuven, Belgium


Current Medical Literature Journals

Current Medical Literature journals are designed to solve the problem of information overload for specialist physicians. Each journal is compiled by an editorial team of clinicians from an ongoing review of the international literature, and articles are selected for citation and review on the basis of their relevance to clinical practice. Other titles in the series include the following. For additional information on any of these titles, please contact us at the address below.

CML – Breast Cancer CML – Lysosomal Storage Diseases
CML – Cardiology CML – Multiple Sclerosis
CML – Colorectal Cancer CML – Neurology
CML – Dermatology CML – Ophthalmology
CML – Diabetes CML – Pediatrics
CML – Gastroenterology CML – Psychiatry
CML – Growth CML – Pulmonary Hypertension
CML – Gynecology & Obstetrics CML – Respiratory Medicine
CML – Kidney Cancer CML – Rheumatology
CML – Leukemia & LymphomaCML – Urology

Priority Journals

In the preparation of this journal, over 2500 journals are reviewed for content relevant to the target audience. The following journals are treated on a priority basis by the Editors.


Acta Oncol Cancer Eur J Surg Oncol Lancet
Am J Clin Oncol Cancer Immunol Immunother Eur Respir JLancet Oncol
Am J Respir Crit Care MedCancer Lett Int J Cancer Lung Cancer
Am J Surg Cancer Res Int J Radiat Oncol Biol Phys N Engl J Med
Ann Intern Med Chest JAMA Oncogene
Ann Oncol Clin Cancer ResJ Cancer Res Clin Oncol Oncology
Ann Thorac Surg Clin Lung Cancer J Clin Oncol Oncology-Basel
Anti-cancer drugs Clin Oncol J Natl Cancer Inst Radiother Oncol
Arch Intern MedCrit Rev Oncol Hemat Jpn J Cancer Res Semin Oncol
BMJ EMBO J J Surg Oncol Thorax
Br J Cancer Eur J Cancer J Thorac Cardiovasc Surg
Br J Surg Eur J Cardiothorac Surg J Thorac Oncol

Acknowledgement

The Current Medical Literature team would like to thank the following publishers for granting us access to their online journal content:
Chest
JAMA and the Archives journals
The New England Journal of Medicine

Correspondence

The Editors look forward to receiving suggestions from readers regarding current papers they think deserve to be featured and which may have been omitted, and on any matter which might improve the series. Please address all correspondence to:

Current Medical Literature, Remedica Medical Education and Publishing, Commonwealth House, 1 New Oxford Street, London WC1A 1NU, UK
Tel: +44 (0)20 7759 2999
Fax: +44 (0)20 7759 2951
Email: info@remedica.com

Editor: Lesley Ezekiel
Email: lesley.ezekiel@remedica.com

Production Controller: Marie Ingram
Email: marie.ingram @ask-skylight.com

Design and artwork: AS&K Skylight Creative Services. Printed in the UK

Disclaimer
© Remedica 2008. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. For detailed information on any drugs or devices discussed in this publication, readers are advised to consult the manufacturer’s prescribing information.

ISSN 1469-6886

READER POLL

Lung Cancer poll 1
When treating advanced, partially resectable large cell neuroendocrine carcinomas of the lung, would you initially treat with:






Powered by NetPolls

SUBMIT AN ARTICLE